Existing studies have confirmed the indispensable role of CXCL13 in ovarian cancer and can act as a biomarker (Yang et al. 2021), but it remains unclear in other gynecologic tumors and breast cancer. This evidence concerns the gene CXCL13 and ovarian cancer.